DK1831240T3 - 18-methyl-19-nor-17pregn-4-en-21, 17-carbolactoner samt farmaceutiske præparater, der indeholder disse - Google Patents

18-methyl-19-nor-17pregn-4-en-21, 17-carbolactoner samt farmaceutiske præparater, der indeholder disse

Info

Publication number
DK1831240T3
DK1831240T3 DK05850392T DK05850392T DK1831240T3 DK 1831240 T3 DK1831240 T3 DK 1831240T3 DK 05850392 T DK05850392 T DK 05850392T DK 05850392 T DK05850392 T DK 05850392T DK 1831240 T3 DK1831240 T3 DK 1831240T3
Authority
DK
Denmark
Prior art keywords
17pregn
carbolactones
ene
methyl
pharmaceutical preparations
Prior art date
Application number
DK05850392T
Other languages
Danish (da)
English (en)
Inventor
Rolf Bohlmann
Dieter Bittler
Hermann Kuenzer
Peter Esperling
Hans-Peter Muhn
Karl-Heinrich Fritzemeier
Ulrike Fuhrmann
Katja Prelle
Frueher Kurz Steffen Borden
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36087369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1831240(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK1831240T3 publication Critical patent/DK1831240T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK05850392T 2004-12-30 2005-12-30 18-methyl-19-nor-17pregn-4-en-21, 17-carbolactoner samt farmaceutiske præparater, der indeholder disse DK1831240T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004063864A DE102004063864A1 (de) 2004-12-30 2004-12-30 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
PCT/EP2005/014205 WO2006072467A1 (de) 2004-12-30 2005-12-30 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische präparate

Publications (1)

Publication Number Publication Date
DK1831240T3 true DK1831240T3 (da) 2009-11-23

Family

ID=36087369

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05850392T DK1831240T3 (da) 2004-12-30 2005-12-30 18-methyl-19-nor-17pregn-4-en-21, 17-carbolactoner samt farmaceutiske præparater, der indeholder disse

Country Status (33)

Country Link
US (1) US20090029953A1 (ru)
EP (1) EP1831240B8 (ru)
JP (1) JP5043681B2 (ru)
KR (1) KR20070093443A (ru)
CN (1) CN101128476B (ru)
AR (1) AR052657A1 (ru)
AU (1) AU2005324055A1 (ru)
BR (1) BRPI0518533A2 (ru)
CA (1) CA2594171C (ru)
CR (1) CR9223A (ru)
CY (1) CY1109498T1 (ru)
DE (2) DE102004063864A1 (ru)
DK (1) DK1831240T3 (ru)
EA (1) EA014325B1 (ru)
ES (1) ES2331322T3 (ru)
GT (1) GT200500394A (ru)
HK (1) HK1112627A1 (ru)
IL (1) IL184288A (ru)
MX (1) MX2007008074A (ru)
MY (1) MY145904A (ru)
NO (1) NO20073257L (ru)
NZ (1) NZ556150A (ru)
PA (1) PA8658401A1 (ru)
PE (2) PE20100736A1 (ru)
PL (1) PL1831240T3 (ru)
PT (1) PT1831240E (ru)
RS (1) RS51128B (ru)
SI (1) SI1831240T1 (ru)
TW (1) TW200635942A (ru)
UA (1) UA90496C2 (ru)
UY (1) UY29320A1 (ru)
WO (1) WO2006072467A1 (ru)
ZA (1) ZA200706254B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027635A1 (de) * 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063501A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063498A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063496A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063500A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063495A1 (de) 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102007063499A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063503A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
EP2265629B1 (en) * 2008-03-05 2015-06-24 Evestra, Inc. Bismethylene-17 carbolactones and related uses
DE102008026793A1 (de) 2008-06-02 2009-12-03 Bayer Schering Pharma Aktiengesellschaft C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
CN101623287B (zh) * 2008-07-07 2012-02-08 天津金耀集团有限公司 一种屈螺酮类似物的治疗更年期综合症的药物组合物
EP2367808A4 (en) * 2008-11-25 2012-05-09 Evestra Inc g-LACTONES OF 3- (6,6-ETHYLENE-17β-HYDROXY-3-OXO-17α-PREGEN-4-EENE-17α-YL) PROGESTATIVE PROPIONIC ACID
WO2010066349A1 (de) * 2008-12-12 2010-06-17 Bayer Schering Pharma Aktiengesellschaft Verwendung von 17beta-cyano-19-androst-4-en-derivaten zur herstellung eines arzneimittels in depot-form zur parenteralen anwendung sowie depot-arzneimittel enthaltend 17beta-cyano-19-androst-4-en-derivate zur parenteralen anwendung
WO2010066354A1 (de) * 2008-12-12 2010-06-17 Bayer Schering Pharma Aktiengesellschaft VERWENDUNG VON 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-EN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS IN DEPOT-FORM ZUR PARENTERALEN ANWENDUNG SOWIE DEPOT-ARZNEIMITTEL ENTHALTEND 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-EN-DERIVATE ZUR PARENTERALEN ANWENDUNG
WO2010066355A1 (de) * 2008-12-12 2010-06-17 Bayer Schering Pharma Aktiengesellschaft VERWENDUNG VON 17β- CYANO-19-NOR-ANDROST-4-EN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS IN DEPOT-FORM ZUR PARENTERALEN ANWENDUNG SOWIE DEPOT-ARZNEIMITTEL ENTHALTEND 17β-CYANO-19-NOR-ANDROST-4-EN-DERIVATE ZUR PARENTERALEN ANWENDUNG
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DE3402329A1 (de) * 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2739029B1 (fr) * 1995-09-21 1997-11-21 Roussel Uclaf Nouvelle application therapeutique des composes antimineralo-corticoides
DE19651000A1 (de) * 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone

Also Published As

Publication number Publication date
KR20070093443A (ko) 2007-09-18
UA90496C2 (ru) 2010-05-11
PE20060853A1 (es) 2006-09-15
EA014325B1 (ru) 2010-10-29
JP2008526709A (ja) 2008-07-24
NZ556150A (en) 2011-02-25
CY1109498T1 (el) 2014-08-13
CR9223A (es) 2007-11-23
MY145904A (en) 2012-05-15
IL184288A0 (en) 2007-10-31
TW200635942A (en) 2006-10-16
PA8658401A1 (es) 2006-08-03
HK1112627A1 (ru) 2008-09-12
EA200701239A1 (ru) 2007-12-28
PE20100736A1 (es) 2010-12-03
RS51128B (sr) 2010-10-31
SI1831240T1 (sl) 2009-12-31
BRPI0518533A2 (pt) 2008-11-25
ZA200706254B (en) 2008-12-31
JP5043681B2 (ja) 2012-10-10
DE502005007723D1 (de) 2009-08-27
IL184288A (en) 2011-06-30
UY29320A1 (es) 2006-07-31
ES2331322T3 (es) 2009-12-29
NO20073257L (no) 2007-08-29
GT200500394A (es) 2006-08-01
AR052657A1 (es) 2007-03-28
EP1831240A1 (de) 2007-09-12
CN101128476B (zh) 2011-02-09
US20090029953A1 (en) 2009-01-29
MX2007008074A (es) 2008-03-10
AU2005324055A1 (en) 2006-07-13
CN101128476A (zh) 2008-02-20
EP1831240B8 (de) 2010-02-17
CA2594171A1 (en) 2006-07-13
PT1831240E (pt) 2009-10-22
EP1831240B1 (de) 2009-07-15
WO2006072467A1 (de) 2006-07-13
CA2594171C (en) 2012-10-16
DE102004063864A1 (de) 2006-07-13
PL1831240T3 (pl) 2010-01-29

Similar Documents

Publication Publication Date Title
DK1831240T3 (da) 18-methyl-19-nor-17pregn-4-en-21, 17-carbolactoner samt farmaceutiske præparater, der indeholder disse
NO20052285D0 (no) Faste, partikkelformige, antifungale preparater for farmasoytisk anvendelse
NL1025404A1 (nl) Pyrazolo-triazine verbindingen en gebruik daarvan.
PL382306A1 (pl) Preparaty przeciwwirusowe do stosowania miejscowego
DE602005003819D1 (de) Perfluoroelastomer- und fluoroplastikgemische
DK1773796T3 (da) Oxopiperidinderivater, fremstilling deraf samt terapeutisk anvendelse deraf
ATE387090T1 (de) Herbizide mittel
DK1898863T3 (da) Etui til optagelse af en lægemiddelspakning samt anvendelse deraf
ZA200900673B (en) 18-methyl-19-nor-androst-4-en-17, 17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same
DE602004028875D1 (de) Turboladergehäuse, turbolader und multiturboladersystem
DK1382947T3 (da) Doseringsanlæg til pulverpigmenter
GB0420062D0 (en) Assay methods,materials and preparations
DK1768691T3 (da) Aequorinholdige præparater og fremgangsmåder til anvendelse af samme
IL180229A0 (en) PROTEIN COMPLEX CONTAINING A HEMAGGLUTININ AND A POLYPEPTIDE-Hc-CONJUGATE AND METHODS FOR THE PREPARATION THEREOF
DK1791872T3 (da) Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf
SE0502071L (sv) Förpackning, förslutningsanordning samt användning därav
IS8548A (is) Úðaþurrkaðar lyfjablöndur
DK1768988T3 (da) Hidtil ukendte phenyl-borsyre-derivater samt fremgangsmåder til fremstilling deraf
NL1025908A1 (nl) Farmaceutische combinatie.
FI20040146A (fi) Farmaseuttiset valmisteet
ATA1612003A (de) Sicherheitscontainer
ITPI20030083A1 (it) Bottale con perfezionamenti costruttivi adatti, in
ES1057139Y (es) Contenedor portatil.
FI8053U1 (fi) Macrogol valmiste
SE0400028D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof